Magnetic Resonance Imaging (MRI) Study of the Hippocampus After Infarction in the Territory of the Middle Cerebral Artery
NCT ID: NCT00867581
Last Updated: 2009-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An fMRI Study of Jianpi Yishen Huatan Granules for Cognitive Impairment After Acute Cerebral Infarction
NCT02752867
High-resolution Magnetic Resonance Imaging of Intracranial Atherosclerotic Plaques in Ischemic Stroke
NCT05897645
MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
NCT01689402
Magnetic Resonance Imaging Studies of Motor and Thought Processes
NCT00001361
Intracranial Artery Stenosis Magnetic Resonance Imaging: Aetiology and Progression
NCT03417063
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
chronic-stage patients after infarction in the territory of unilateral middle cerebral artery
No interventions assigned to this group
2
age, sex and risk factor matched volunteers without ischemic stroke
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least six months from the stroke
* Must be able to measure his(her) neuropsychologic function (by MMSE, AVLT)
Exclusion Criteria
* Severe dementia, apraxia, disturbances of sensation or perception
* Serious complications including severe heart failure, hepatic dysfunction, renal insufficiency,or shock
* Parkinson's disease, malignant tumor, autoimmune diseases
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Huazhong University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Neurology of Tongji Hospital, Huazhong University of Sci. and Tec
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wei Wang, Doctor
Role: PRINCIPAL_INVESTIGATOR
Tongji Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurology of Tongji Hospital, Huazhong University of Science and Technology
Wuhan, Hubei, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
30725019-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.